Metabolomic biomarkers of polycystic ovary syndrome related-obesity: a review of the literature
Background and objectives: Polycystic ovary syndrome (PCOS) displays a phenotype-dependent cardio-metabolic risk. By performing a systematic search of the literature, we aimed to summarize metabolomic signatures associated with obesity in PCOS women.
Main Authors: | Vonica Camelia Larisa, Farcas Anca Daniela, Roman Gabriela, Muresan Andrada Alina, Fodor Adriana, Cernea Simona, Georgescu Carmen Emanuela |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2020-07-01
|
Series: | Romanian Journal of Laboratory Medicine |
Subjects: | |
Online Access: | https://doi.org/10.2478/rrlm-2020-0017 |
Similar Items
-
Correlation Between Fecal Metabolomics and Gut Microbiota in Obesity and Polycystic Ovary Syndrome
by: Ling Zhou, et al.
Published: (2020-09-01) -
Multi-omics analyses reveal the specific changes in gut metagenome and serum metabolome of patients with polycystic ovary syndrome
by: Zhandong Yang, et al.
Published: (2022-10-01) -
Metabolomic Insight into Polycystic Ovary Syndrome—An Overview
by: Anna Rajska, et al.
Published: (2020-07-01) -
Alterations of Gut Microbiome and Fecal Fatty Acids in Patients With Polycystic Ovary Syndrome in Central China
by: Gailing Li, et al.
Published: (2022-07-01) -
Integrated lipid metabolomics and proteomics analysis reveal the pathogenesis of polycystic ovary syndrome
by: Yu Qian, et al.
Published: (2024-04-01)